Steve Aselage Biocryst Pharmaceuticals Inc (BCRX) insider trading activity
Steve Aselage is Director of BIOCRYST PHARMACEUTICALS INC. Currently has a direct ownership of 70,159 shares of BCRX, which is worth approximately $531,103. The most recent transaction as insider was on Jun 12, 2024, when has been sold 6,820 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
70.2K
0%
3M change
10.77%
12M change
Total Value Held
$531,103
STEVE ASELAGE Transaction History
Also insider at
SA
Steve Aselage
Director
Durham, NC